Roche’s drug production operations are set to benefit from the company’s updated U.S. strategy, including with “expanded and ...

The mandate overrules Section 4.1.2 “Civil Rights Protections” of the NIH Grants Policy Statement, which includes the Civil ...

Harvard University is suing President Trump's administration over its threats to freeze billions in research funding. | Harvard University is suing President Trump's administration over its threats to ...

The National Institutes of Health (NIH) is halting new grant and contract payments to several universities, a move the agency ...

It’s been five years since the U.K.’s breakup with the European Union, and the impacts of extra red tape and rising costs ...

That means the future of Roivant is tied to the success, or otherwise, of Immunovant’s attempts to break into the FcRn market ...

Tempest Therapeutics is hunkering down to weather the storm that has engulfed its operations. | Tempest Therapeutics is ...

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...

Charles River initially unveiled a plan to adopt new alternative methods (NAMs), like computer models and human organoids, in ...

Biotechs will need to be strategic to achieve “tariff-era success” as the sector enters an “America-first resurgence,” ...

After mass layoffs, the FDA has started missing certain deadlines, pushing one biopharma to delay a phase 3 trial and ...

Alis Biosciences has made a pitch to the hundreds of biotechs that are valued at less than the cash they have in the bank.